3Predicting the development of RA in patients with early undifferentiated arthritis
Section snippets
Predicting the development of persistent arthritis in patients with early synovitis
A number of studies have addressed predictors of the development of persistent arthritis in patients presenting with early synovitis. In one of the first such studies, Tunn and Bacon identified seropositivity for rheumatoid factor (RF) and an erythrocyte sedimentation rate (ESR) >30 mm/h as the best predictors in a cohort of patient with synovitis of up to 6 months' duration. The specificity of these two variables was 94%, but the sensitivity was only 69% for the prediction of persistence [1].
Predicting the development of RA in patients with early synovitis
Any discussion of approaches to predicting the development of RA must begin with a consideration of what we mean by this diagnosis. In contrast to the difficulty in identifying widely accepted definitions of remission and persistence, the current definition of RA is used almost universally, despite attracting its fair share of controversy [12], [13]. Current classification criteria were developed by a committee appointed by the American Rheumatism Association to revise the 1958 diagnostic
Serology
It is clear that the description of antibodies reactive against citrullinated proteins/peptides (ACPAs) has been an important development in our ability to predict outcome in patients with early synovitis. Current widely used approaches to the detection of these antibodies use synthetic cyclic peptides containing citrulline residues. Such assays have a very high specificity but a relatively low sensitivity. There has been great interest in the identification of substrates which allow the
Genetics
The most important genetic risk factor for RA was identified 30 years ago [23], and there is now extensive evidence that certain HLA-DRB1 alleles, which share the conserved shared epitope, are associated with susceptibility to RA. The lack of contribution of these alleles to the prediction rule developed by the Leiden group for use in undifferentiated arthritis patients [18] is likely to be due to the fact that these alleles are associated with the presence of anti-CCP antibodies [24] which are
Synovial pathology
Although the synovium is the primary site of pathology in RA, and much emphasis is placed on clinical patterns of joint inflammation in the diagnosis of RA and the prediction of outcome, there has been remarkably little work carried out addressing whether aspects of synovial pathology can distinguish patients with early arthritis destined to develop RA from those destined to develop other conditions. Important work from Schumacher and colleagues has helped characterize the histological and
Imaging of synovitis: potential role in early undifferentiated arthritis
Assessment of the pattern and extent of joint involvement in inflammatory disease fulfils a crucial role in classification criteria for RA [14], assessment of disease activity [60], response to therapy [61], and remission [62]. Three of the 1987 ACR criteria [14] depend upon clinical assessment of the pattern of joint involvement, defining the number of joints involved, the involvement of hand joints, and symmetry. Similar factors have proved to be important in the field of undifferentiated
Imaging of bone changes: potential role in early undifferentiated arthritis
Erosions are considered pathognomonic of the more severe forms of RA. Identification of bone changes in severe RA is traditionally the territory of the plain radiograph, which has no useful role in the identification of synovitis. However, in parallel with the detection of synovitis, the more advanced imaging techniques of MRI and US have demonstrated superior sensitivity for detection of erosive change. Wakefield et al in 2000 published that US was able to successfully identify 127 erosions in
Summary
On the basis of clinical and serological features we are now able to accurately predict the development of RA in a large proportion of patients presenting with undifferentiated synovial swelling. Ongoing work looking at the assessment of synovial tissue obtained by biopsy and the imaging of synovium and surrounding structures using increasingly widely available approaches will provide new and rational parameters to input into predictive algorithms; it is hoped that these will improve our
Conflict of interest
Karim Raza has received research grants from Wyeth, UCB Celltech, Cellzome and Pfizer. He has received honoraria from Wyeth. Andrew Filer has received research grants from Cellzome and Pfizer.
References (84)
- et al.
Treating very early rheumatoid arthritis
Best Pract Res Clin Rheumatol
(2006) - et al.
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis
Am J Hum Genet
(2004) - et al.
Histological appearance of the synovium in early rheumatoid arthritis
Semin Arthritis Rheum
(1994) - et al.
The synovial membrane as a prognostic tool in rheumatoid arthritis
Autoimmun Rev
(2007) - et al.
Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic
Br J Rheumatol
(1993) - et al.
Natural remission in inflammatory polyarthritis: issues of definition and prediction
Br J Rheumatol
(1996) - et al.
Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis
Rheumatology (Oxford)
(2004) - et al.
Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
Arthritis Rheum
(2002) Patients with suspected rheumatoid arthritis should be referred early to rheumatology
BMJ
(2008)- et al.
Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope
Arthritis Rheum
(1999)
The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide
Arthritis Rheum
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
Arthritis Res
How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis
Arthritis Rheum
Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years
Rheumatology (Oxford)
Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis
Arthritis Rheum
Classification criteria for rheumatoid arthritis – time to abandon rheumatoid factor?
Rheumatology (Oxford)
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
Arthritis Rheum
The value of the ACR 1987 criteria in very early rheumatoid arthritis
Scand J Rheumatol
Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis
J Rheumatol
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis
Ann Rheum Dis
A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions
Arthritis Rheum
Moving towards individualized treatment decision making: validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis
Arthritis Rheum
The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association
J Rheumatol
Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides
Arthritis Rheum
Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis
Arthritis Res Ther
Association of the B-cell alloantigen DRw4 with rheumatoid arthritis
N Engl J Med
The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis
Arthritis Rheum
Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort
Arthritis Rheum
A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis
PLoS Medicine
TRAF1-C5 as a risk locus for rheumatoid arthritis – a genomewide study
N Engl J Med
Rheumatoid arthritis association at 6q23
Nat Genet
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles
Arthritis Rheum
Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis
Arthritis Rheum
Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis
Arthritis Rheum
IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis
Ann Rheum Dis
Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis
Arthritis Rheum
Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis
Arthritis Rheum
Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
Arthritis Res Ther
Synovitis of recent onset. A clinicopathologic study during the first month of disease
Arthritis Rheum
Quantitative analysis of immunohistologic features of very early rheumatoid synovitis in disease modifying antirheumatic drug- and corticosteroid-naive patients
J Rheumatol
How useful are synovial biopsies for the diagnosis of rheumatic diseases?
Nat Clin Pract Rheumatol
Ultrasound guidance allows accurate needle placement and aspiration from small joints in patients with early inflammatory arthritis
Rheumatology (Oxford)
Cited by (26)
Sonographic cutoff values for detection of abnormalities in small, medium and large joints: A comparative study between patients with rheumatoid arthritis and healthy volunteers
2015, Ultrasound in Medicine and BiologyCitation Excerpt :Accordingly, recent studies have reiterated the need for the early diagnosis of this potentially destructive disease (Bartok and Firestein 2010), and several attempts have been made to find potential predictors of its development. Some serologic, genetic and synovial pathology aspects have already been mentioned in the literature as potential predictors of RA (Raza and Filer 2009); recently, imaging has also gained importance for this objective (Raza and Filer 2009). In recent years, ultrasound has been used in rheumatologic clinical practice as a supplemental physical examination (Grassi 2003), because of its unquestionable diagnostic potential (Grassi et al. 2004).
Pathogenesis of rheumatoid arthritis: From systemic autoimmunity to localised joint disease
2014, Drug Discovery TodayUltrasonography in rheumatoid arthritis: What rheumatologists should know
2013, Revista Brasileira de ReumatologiaAutoantibodies in Rheumatoid Arthritis
2012, Kelley's Textbook of Rheumatology: Volume 1-2, Ninth EditionSpontaneously Resolving Joint Inflammation Is Characterised by Metabolic Agility of Fibroblast-Like Synoviocytes
2021, Frontiers in Immunology